Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Senile plaques are primarily comprised of deposits of the beta-amyloid precursor-like proteins APLP1 and
APLP2
. proteins (APPs). APP is a member of a gene family, including amyloid precursor-like proteins APLP1 and
APLP2
. Using interspecific mouse backcross mapping, we localized the mouse
APLP2
gene to the promixmal region of mouse chromosome 9, syntenic with a region of human 11q. We cloned an approximately 1.2-kilobase mouse genomic fragment containing the
APLP2
gene promoter. The
APLP2
promoter lacks a typical TATA box, is GC-rich, and contains several sequences for transcription factor binding.
S1 nuclease
protection analysis revealed the presence of multiple transcription start sites. The lack of a TATA box, the presence of a high GC content, and multiple transcription start sites place the
APLP2
promoter in the class of promoters of "housekeeping genes." Regulatory regions within the promoter were assayed by transfection of mouse N2a and Ltk- cells with constructs containing progressive 5'-deletions of the
APLP2
promoter fused to the bacterial chloramphenicol acetyl transferase (CAT) reporter gene. A minimal region that includes sequences 99 bp upstream of the predominant transcription start site of the
APLP2
promoter was sufficient to direct high levels of CAT expression.
...
PMID:The mouse APLP2 gene. Chromosomal localization and promoter characterization. 759 16